JDRF renews grant support for study examining stem cell transplants for diabetes JDRF is the leading charitable funder of research into type 1 diabetes in Canada, with a focus on research that will help improve lives today, and lead to disease prevention and cures. As part of this commitment, JDRF is renewing its support of […]
On June 28th, 2021 endurance athlete and JDRF ambassador Sébastien Sasseville took on his greatest challenge yet. A commitment to ride a bicycle across Canada in support of universal access to diabetes devices for all Canadians living with the disease. Sébastien was diagnosed with Type 1 diabetes in 2002. He vowed that T1D would never […]
This summer, Medtronic® is challenging Canadians to take the Blue Balloon Challenge to raise awareness of how difficult it is to balance the ups and downs of life with type 1 diabetes (T1D). People living with T1D have to make 300 or more decisions every day to keep their blood sugar levels in check. This […]
The 2021 Sun Life Walk to Cure Diabetes for JDRF brought together Canadians from coast to coast to unite and raise funds to accelerate the pace of type 1 diabetes (T1D) research. We’re so excited to have had members of the community come together in our brand new, Virtual Walk Environment, mingle with friends old and new, explore our sponsor […]
Connect1d Canada is a digital platform that allows those living with type 1 diabetes (T1D) to easily learn about T1D research happening across Canada, and contribute to research in the areas that matter most to them. The platform also allows researchers to easily engage people living with T1D, enabling rapid recruitment of diverse people from across […]
To commemorate the 100th anniversary of the discovery of insulin, JDRF launched the $100M Campaign to Accelerate – a bold initiative to help finally free people from the monster that is type 1 diabetes (T1D). Though the pandemic posed challenges across industry, individuals working in commercial real estate came together to help JDRF achieve its […]
Learn the latest on type 1 diabetes research updates Our research roundup brings you the most exciting type 1 diabetes (T1D) research stories globally, including new clinical trials, treatment advances and research projects that are making the biggest impact in curing and preventing T1D, while improving lives today. Here’s what you need to […]
Up until now, Canada has been without a national diabetes strategy. But thanks to the work of tireless advocates and diabetes organizations, on June 21, 2021 Bill C-237 an Act to Establish a National Diabetes Framework, was passed by the Senate. The passage of the bill means that the federal government is poised to take […]
There has been some great progress made recently towards greater access to diabetes devices and federal commitments to funding and incorporating a national diabetes strategy. These have only been achieved through collaboration with partners and other diabetes organizations and on the strength of our volunteers. We rely on a network of passionate volunteer advocates to […]
Access for All was launched in 2019 and has already driven major change. We are fortunate to have some of the most powerful young voices in the country advocating for our mission. These dedicated individuals have rallied communities across the country, and now several provinces and territories are in the process of revisiting their coverage […]
Summer is here and as Canadians are getting vaccinated against COVID-19, we have decided to take a break from our live Let’s Talk T1D events on Microsoft Teams, and package them in a way that is more convenient for the summer months. More Canadians are getting vaccinated against COVID-19 and restrictions across the country are easing. The […]
Type 1 diabetes is an autoimmune disease resulting in a lifelong dependency on insulin treatment and a risk of serious long-term complications. The cause of the disease is unclear, although both genes and factors in the environment seem to be important. As new cases of this burdensome and costly disease are on the rise in […]
